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RESULTS
The diameter of the ferro-fluid particles was determined by placing a sample of the
solution onto asilicon wafer for an examination in a Scanning Electron Microscope
(SEM), which on average was 147 nm. The ferro-fluid sample was sputter coated with
gold particles. For further investigation, the sample was put under a localized Energy-
dispersive X-ray spectroscopy (EDX).
It was determined that by wrapping several layers
of coils, each layer wrapped around the previous
layer with wires in parallel circuits to another,
one could achieve high Gauss ratings within
the fluid domain at lower power requirements.
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CARDIOVASCULAR ENGINEERING RESEARCH : 
DEVELOPMENT OF A MAGNETICALLY-DRIVEN VENTRICULAR ASSIST DEVICE
BACKGROUND
Currently, over 5 million people in the United States alone suffer from heart failure [1].
This led to the development of a bridge to transplantation device, or Left Ventricular
Assist Device (LVAD), that would provide patients more time while waiting for a viable
transplant. Although the LVAD has proven to be a successful medical device, the
formation of thromboembolisms is still a major health risk. A thrombus, or particulate
matter, can form inside the LVAD due to the rotary function of its moving parts.
Around 8% of all newborns with a Congenital Heart Defect (CHD) have a single
functioning ventricle which is a condition known as Hypoplastic Left Heart Syndrome
(HLHS). The Fontan operation has served as the 3rd stage palliation for this anomaly
for decades but the surgery entails multiple complications and survival rate is less than
50% by adulthood.
GOAL
Develop a magnetically-driven ventricular assist device without moving parts that will
provide assistance to the Fontan cardiovascular circulation.
METHODS
The design of the magnetically-driven ventricular assist device (MVAD) consists of two
parts: an electromagnet and ferro-fluid. The MVAD will be tested within the mock
circulatory loop which simulates the circulatory system of a 10-year-old male who
received the Fontan surgery for Hypoplastic Left Heart Syndrome as an infant.
The electromagnet will be made to produce a magnetic field in order to increase the
velocity of the flow. The velocity field u of the fluid domain is governed by the Navier-
Stokes equations such that,
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Where F is the Volumetric Body Force exerted on the fluid. In the case of this
experiment, the MVAD produces this body force as a result of the magnetic field acting
on the ferrous nanoparticles. The magnetic force can be calculated such that,
𝑭𝑭 = 𝑚𝑚 � 𝛻𝛻 𝑩𝑩 (2)
Where m is the magnetic dipole moment and B is the magnetic flux density
provided by the inductance of the electromagnetic coil. The magnetic flux density is
directly proportional to magnetic intensity with permeability constant, for a particular
medium, where,
𝑩𝑩 = 𝜇𝜇𝜇𝜇 (3)
Using these concepts, the magnetic flux density provided by the electromagnet as,
𝑩𝑩 = 𝜇𝜇𝑯𝑯 + 𝑩𝑩𝒓𝒓𝒓𝒓𝒓𝒓 (4)
Where Brem is the remnant flux density.
A Ferro-fluid is produced using an appropriate ratio of Ferrous Chloride (FeCl2-) and
Ferric Chloride (FeCl3) solutions mixed together in a base solution of ammonia (NH3).
The solution is kept at a steady temperature of around 50 degrees Celsius by resting
on a hot plate under constant homogenization. Oleic Acid is used as a surfactant to
inhibit clumping. The solution is centrifuged to eliminate ammonium hydroxide and to
segregate the magnetite particles. The excess liquid is then replaced with Polyethylene
Glycol (PEG).
ABSTRACT
The current state of the art device used to aid patients with end stage heart
failure, Left Ventricular Assist Device (LVAD), still exhibits risks that cause
thromboembolisms to enter the bloodstream, which can lead to strokes and
death. These risks occur due to the rotary function and small moving parts of
the LVAD which cause particulate matter in the blood to form thrombi.
The proposed Magnetically-Driven Ventricular Assist Device (MVAD) will
remove the existence of moving parts while still increasing momentum in blood
flow. The development of the MVAD consists of an electromagnet and a ferro-
fluid that will be tested on the mock circulatory loop. The mock circulatory loop
has been calibrated to the anatomical values of an infant with Hypoplastic Left
Heart Syndrome.
The synthesis of the ferro-fluid has resulted in average particle diameters of 147
nm, which are used in concentrations of 10%, 25%, and 50%. The sensors of
the mock circulatory loop have been calibrated to account for the addition of the
ferro-fluid solution instead of water. The electromagnet prototypes will be
wrapped in multiple layers of about 45 wraps in each layer.
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Figure 2: Mock Circulatory Loop 
Figure 6: Electromagnet prototype 
with layered wraps of 28 gauge 
magnet wire. 
Figure 7: Sample under SEM with Quanta 
of 50 µm and magnification factor of 1200.
Figure 8: Nanoparticles under SEM 
with magnification factor of 119190.
Figure 9: Distribution of 
elements present in EDX 
sample along with their 
energy levels. 
Figure 3: Lumped Parameter 
Model of the Body 
Layer Turns 1.5 A 2.5 A
1 50 28.8 G 43.3 G
2 47 47.4 G 77.6 G
3 44 67.2 G 113.5 G
4 42 85.6 G 144.0 G
Figure 10: Electromagnet Prototype 
Magnetic Flux with multiple layers 
